Browsing Health Sciences by Subject "Imatinib mesylate"
Now showing items 1-1 of 1
-
What happens to intolerant, relapsed or refractory chronic myeloid leukemia patients without access to clinical trials?
(2019) [Journal article]Objective: To assess clinical outcomes of intolerant, relapsed or refractory patients who could not be treated with new tyrosine kinase inhibitors or experimental therapies. Methods: A retrospective cohort of 90 chronic ...